1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
(
- Contribution to journal › Article
- 2024
-
Mark
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma
(
- Contribution to journal › Article
-
Mark
FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology
(
- Contribution to journal › Article
- 2022
-
Mark
Difficulties in diagnostics of lung tumours in biopsies : An interpathologist concordance study evaluating the international diagnostic guidelines
(
- Contribution to journal › Article
- 2021
-
Mark
A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated with Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor) : A Report of 22 Cases
(
- Contribution to journal › Article
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
(
- Contribution to journal › Article
-
Mark
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
(
- Contribution to journal › Article
-
Mark
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
(
- Contribution to journal › Article